Our findings provide strong evidence detectable levels of hs-cTnT, an indicator of SMN, is prevalent in patients with prediabetes undergoing elective diagnostic cardiovascular risk evaluation. This evidence concerns the gene TNNT2 and prediabetes syndrome.